According to a market report by Lucintel, the future of the global morphine market looks promising with opportunities in the hospitals & clinics and ambulatory surgical centers markets. The global morphine market is expected to grow with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are surge in cancer and other disease cases accentuates and escalating utilization of morphine for pain management.
In this market, injection and oral tablets are the major segments of morphine market by dosage form.
Lucintel forecasts that injection will remain the largest segment over the forecast period due to growing occurrence of neurological diseases.
Within this market, hospitals and clinics will remain the largest segment due to high prescriptions.
North America will remain the largest region over the forecast period due to surging prevalence of chronic diseases.
Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industries, Macfarlan Smith, Sun Pharmaceutical Industries, Qinghai Pharmaceutical, Northeast Pharmaceutical, Pfizer, and Verve Health Care are the major suppliers in the morphine market.
This unique report from Lucintel will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected]